Quantcast

Latest Multiple drug resistance Stories

2009-07-10 07:00:00

MORGANTOWN, W.Va., July 10 /PRNewswire-USNewswire/ -- Combat-related injuries have long plagued the military in part because of multidrug-resistant bacteria. Imagine being able to spray a compound fracture with microcapsules that deliver a drug to bolster the immune system, stopping infection before it starts. That technology might be around the corner, says Bingyun Li, Ph.D., of the West Virginia University Department of Orthopaedics and director of the WVU Biomaterials, Bioengineering...

2009-06-30 07:00:00

NEW HAVEN, Conn., June 30 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic resistant infections, announced today that Russell Greig, Ph.D., of SR One venture capital, has been appointed to the Company's Board of Directors. Rib-X's board now consists of eleven members. "We are extremely pleased that Russell Greig has joined the Rib-X Board of Directors," said Dr. Susan...

2009-06-19 10:38:00

SOMERSET, N.J., June 19 /PRNewswire-FirstCall/ -- Dear Shareholder, I am grateful to have this opportunity to share with you important developments taking place at this critical juncture in our company history. This communication shall mark what I hope will be the first of many as your president. Like many of you, I also have been a longtime shareholder and supporter of this company. I want you to know I am fully committed no matter how difficult the challenge, to see this company and...

2009-06-11 13:43:12

Some disease-causing bacteria are becoming resistant to antibiotics because they have peculiar sex lives, say researchers publishing new results today in the journal Science. The new study helps scientists understand how bacteria develop resistance to antibiotics, which is a major challenge for those treating infectious diseases, say the authors from Imperial College London.Today's research looks at bacteria called pneumococcus (Streptococcus pneumoniae), which cause diseases including...

2009-05-21 20:12:00

SAN MARINO, Calif., May 21 /PRNewswire-FirstCall/ -- Biotechnology firm Viral Genetics, Inc. (Pink Sheets: VRAL), a company that discovers and develops drug compounds to treat cancer, Lyme Disease and HIV, has been issued a patent for novel cancer therapies. The patent protects cancer drugs that have been tested in pre-clinical research studies in mice. Issued on March 31, 2009, the U.S. Patent Number is: 7,510,710. Additional patents directed at generic classes of the drugs are still...

2009-05-13 10:00:27

For bacteria in wastewater treatment plants, the stars align perfectly to create a hedonistic mating ground for antibiotic-resistant superbugs eventually discharged into streams and lakes. In the first known study of its kind, Chuanwu Xi of the University of Michigan School of Public Health and his team sampled water containing the bacteria Acinetobacter at five sites in and near Ann Arbor's wastewater treatment plant. They found the so-called superbugs"”bacteria resistant to multiple...

2009-05-06 09:37:48

Inhibiting the "drug efflux pumps" in bacteria, which function as their defence mechanisms against antibiotics, can mask the effect of mutations that have led to resistance in the form of low-affinity drug binding to target molecules in the cell. This is shown by researchers at Uppsala University in a new study that can provide clues to how the development of resistance to antibiotics in bacteria can be delayed.The introduction of antibiotics as drugs in the treatment of bacterial infections...

2009-04-27 06:00:00

Unique GeneXpert(R) System Capabilities Enable Powerful New TB Diagnostic Tool SUNNYVALE, Calif., April 27 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the release of Xpert(R) MTB/RIF as a CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. For the first time, European clinicians will have access to a rapid test that can simultaneously identify Mycobacterium tuberculosis (MTB) and resistance to rifampicin (RIF), a common first-line...

2009-04-20 07:30:00

- Wiggins Joins from Biogen Idec - SAN DIEGO, April 20 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced that Mark Wiggins has joined the company as Chief Business Officer. Mr. Wiggins comes to Mpex from Biogen Idec, Inc. where he most recently served as Executive Vice President of Business Development, and was a member of the Executive Committee. At Mpex he will be focusing on commercial planning and business development activities related to the company's lead product, MP-376....

2009-04-13 11:30:21

Residents of nursing homes are one of the main reservoirs of anti-microbial resistant bacteria, U.S. researchers said. Study leader Dr. Erin' O'Fallon, a geriatrician at Hebrew Rehabilitation Center and a research fellow in medicine at Harvard Medical School in Boston said that the prevalence of a certain form of drug-resistant bacteria -- multidrug-resistant gram-negative organisms -- far surpassed that of two other common antimicrobial-resistant infections in long-term care facilities....


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related